2017 Dermatomyositis pipeline market report of on global industry analysis and opportunity assessment H1 report provides comprehensive information on the therapeutics under development for Dermatomyositis (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. Get Discount on this Research Report at http://www.reportsnreports.com/contacts/discount.aspx?name=1020045 Lack of blood flow and oxygen to the heart muscle lead to cardiac ischemia, also called Dermatomyositis. The signs and symptoms may include chest pain, typically on the left side of the body (angina pectoris), neck or jaw pain, shoulder or arm pain, clammy skin, shortness of breath and nausea and vomiting. Dermatomyositis can be caused by conditions such as coronary artery disease (atherosclerosis), blood clot, coronary spasm and severe illnesses. The factors that may increase the risk of developing Dermatomyositis include tobacco, diabetes, high blood pressure, high blood cholesterol or triglyceride levels, lack of physical activity, obesity and family history. Dermatomyositis pipeline companies are Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Hope Pharmaceuticals Inc, Idera Pharmaceuticals Inc, KPI Therapeutics Inc, Marathon Pharmaceuticals LLC, MedImmune LLC, Neovacs SA, Novartis AG, Octapharma AG, Pfizer Inc. Drug Profiles of Dermatomyositis anabasum, baricitinib, dalazatide, immune globulin, IMO-8400, MEDI-7734, MP-117, siponimod, sodium thiosulfate, tocilizumab, tofacitinib citrate Purchase this research report Direct from http://www.reportsnreports.com/purchase.aspx?name=1020045 (This report is available at upto 25% Discount till June 02nd 2017.) Scope - The pipeline guide provides a snapshot of the global therapeutic landscape of Dermatomyositis (Musculoskeletal Disorders). - The pipeline guide reviews pipeline therapeutics for Dermatomyositis (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Dermatomyositis (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Dermatomyositis (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Dermatomyositis (Musculoskeletal Disorders) Inquire more on this Research Report at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1020045 List of Tables Number of Products under Development for Dermatomyositis, H1 2017 Number of Products under Development by Companies, H1 2017 Products under Development by Companies, H1 2017 Number of Products by Stage and Target, H1 2017 Number of Products by Stage and Mechanism of Action, H1 2017 Number of Products by Stage and Route of Administration, H1 2017 Number of Products by Stage and Molecule Type, H1 2017 Dermatomyositis - Pipeline by Eli Lilly and Company, H1 2017 Dermatomyositis - Pipeline by F. Hoffmann-La Roche Ltd, H1 2017 Dermatomyositis - Pipeline by Hope Pharmaceuticals Inc, H1 2017 Dermatomyositis - Pipeline by Idera Pharmaceuticals Inc, H1 2017 Dermatomyositis - Pipeline by KPI Therapeutics Inc, H1 2017 Dermatomyositis - Pipeline by Marathon Pharmaceuticals LLC, H1 2017 Dermatomyositis - Pipeline by MedImmune LLC, H1 2017 Dermatomyositis - Pipeline by Neovacs SA, H1 2017 Dermatomyositis - Pipeline by Novartis AG, H1 2017 Dermatomyositis - Pipeline by Octapharma AG, H1 2017 Dermatomyositis - Pipeline by Pfizer Inc, H1 2017 Dermatomyositis - Dormant Projects, H1 2017 About Us: ReportsnReports.com is single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help in purchase decision by mapping your information needs with our huge collection of reports.